glp 1 and dementia GLP-1R agonists protect against Alzheimer's disease by rewiring energy regulation How GLP-1s Could Transform Alzheimer's

"In combination with diet and exercise, Wegovy is the only obesity medicine proven to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight

Health insurance companies and health plans vary greatly in how policies cover weight loss drugs, Cutler explained

Accessed May 31, 2026.

"DPP-4 Inhibitor-Induced Rheumatoid Arthritis Among Diabetics: A Nested Case-Control Study"

The FLOW trial demonstrated clear kidney and cardiovascular protection with GLP-1 receptor agonist (GLP-1RA) treatment in individuals with type 2 diabetes and chronic kidney disease (CKD)

LTSD protects delicate proteins like Lactoferrin from being destroyed by heat, ensuring the product retains its full functional health benefits for gut repair and metabolism.